BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12438324)

  • 1. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice.
    Biet F; Kremer L; Wolowczuk I; Delacre M; Locht C
    Infect Immun; 2002 Dec; 70(12):6549-57. PubMed ID: 12438324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes.
    O'Donnell MA; Aldovini A; Duda RB; Yang H; Szilvasi A; Young RA; DeWolf WC
    Infect Immun; 1994 Jun; 62(6):2508-14. PubMed ID: 8188376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequencies of IFN gamma- and IL-4-producing cells during Mycobacterium bovis BCG infection in two genetically susceptible mouse strains: role of alpha/beta T cells and NK1.1 cells.
    Teixeira HC; Munk ME; Kaufmann SH
    Immunol Lett; 1995 May; 46(1-2):15-9. PubMed ID: 7590911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo immunomodulation following intradermal injection with DNA encoding IL-18.
    Kremer L; Dupré L; Wolowczuk I; Locht C
    J Immunol; 1999 Sep; 163(6):3226-31. PubMed ID: 10477591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
    Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
    Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6.
    Fan XL; Yu TH; Gao Q; Yao W
    Acta Biochim Biophys Sin (Shanghai); 2006 Oct; 38(10):683-90. PubMed ID: 17033714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults.
    Szpakowski P; Biet F; Locht C; Paszkiewicz M; Rudnicka W; Druszczyńska M; Allain F; Fol M; Pestel J; Kowalewicz-Kulbat M
    J Immunol Res; 2015; 2015():359153. PubMed ID: 26339658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.
    Satchidanandam V; Kumar N; Jumani RS; Challu V; Elangovan S; Khan NA
    PLoS Pathog; 2014 Jun; 10(6):e1004176. PubMed ID: 24945624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice.
    Huygen K; Abramowicz D; Vandenbussche P; Jacobs F; De Bruyn J; Kentos A; Drowart A; Van Vooren JP; Goldman M
    Infect Immun; 1992 Jul; 60(7):2880-6. PubMed ID: 1612754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH; Sun Z; Yang XL; Bao L
    Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y; Bao L; Yang X
    Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Mycobacterium bovis BCG expressing the chimeric protein of antigen 85B and ESAT-6 enhances the Th1 cell-mediated response.
    Xu Y; Liu W; Shen H; Yan J; Qu D; Wang H
    Clin Vaccine Immunol; 2009 Aug; 16(8):1121-6. PubMed ID: 19515867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.